Actively Recruiting
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Led by Massachusetts General Hospital · Updated on 2026-04-24
100
Participants Needed
1
Research Sites
409 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this research study we want to learn more about the use of indocyanine green (ICG) during bone or soft tissue mass resections. Indocyanine green (ICG) is a type of dye that is used in medical diagnostics. We want to determine if ICG-guided tumor resection is more effective in obtaining negative margins. Lastly, we want to assess traditional oncologic outcomes of local recurrence, time to metastatic disease, and overall and disease specific survival.
CONDITIONS
Official Title
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older
- Diagnosed with a benign or malignant bone or soft tissue mass
- Scheduled for surgery at Massachusetts General Hospital Department of Orthopaedic Surgery
- Able to provide consent during the study period
You will not qualify if you...
- Pregnant or nursing patients
- Known severe allergy or anaphylaxis to IV contrast or iodine
- Patients with kidney failure not cleared for ICG administration by their primary physician or oncologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
S
Santiago A Lozano-Calderon, MD, PhD
CONTACT
S
Shreya Halur, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here